发明名称 |
Combination of organic compounds |
摘要 |
The present invention relates to a combination, especially a pharmaceutical composition, comprising as active ingredients (i) a HMG-CoA reductase inhibitor or a or a pharmaceutically acceptable salt thereof; (ii) (a) an insulin secretion enhancer or a pharmaceutically acceptable salt thereof or (b) an insulin sensitizer or a pharmaceutically acceptable salt thereof; and, in case of a pharmaceutical composition, a pharmaceutically acceptable carrier.
|
申请公布号 |
US2004002519(A1) |
申请公布日期 |
2004.01.01 |
申请号 |
US20030393798 |
申请日期 |
2003.03.21 |
申请人 |
DAMON ROBERT EDSON;HUGHES THOMAS EDWARD |
发明人 |
DAMON ROBERT EDSON;HUGHES THOMAS EDWARD |
分类号 |
A61K45/00;A61K31/015;A61K31/155;A61K31/175;A61K31/198;A61K31/21;A61K31/22;A61K31/225;A61K31/366;A61K31/40;A61K31/401;A61K31/4035;A61K31/404;A61K31/426;A61K31/433;A61K31/435;A61K31/4418;A61K31/4439;A61K31/4453;A61K31/47;A61K31/505;A61K31/5415;A61K31/64;A61P1/04;A61P1/16;A61P3/00;A61P3/04;A61P3/06;A61P3/10;A61P5/14;A61P5/24;A61P5/50;A61P9/00;A61P9/04;A61P9/10;A61P9/12;A61P13/12;A61P15/00;A61P15/10;A61P17/00;A61P19/04;A61P27/02;A61P27/12;A61P43/00;(IPC1-7):A61K31/443 |
主分类号 |
A61K45/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|